Skip to content
  • Home
  • SEAPRWire
  • ACN
  • JCN
  • EQS
  • Contact

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
  • Home
  • SEAPRWire
  • ACN
  • JCN
  • EQS
  • Contact
Singdao Times
Singdao Times
Latest Singapore News, Events and Headlines

clinical

ACN Newswire
Read More

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

indie 15 August
3 minutes

HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, […]

ACN Newswire
Read More

Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award 2022”

indie 25 July
3 minutes

SYDNEY, Jul 25, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative […]

ACN Newswire
Read More

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

indie 29 June
2 minutes

SEOUL, S.KOREA, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today […]

ACN Newswire
Read More

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

indie 23 June
4 minutes

CHICAGO, IL, Jun 23, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded […]

ACN Newswire
Read More

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

indie 15 June
4 minutes

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based […]

ACN Newswire
Read More

Novotech’s APAC and USA Leadership Teams at BIO 2022

indie 15 June
3 minutes

SAN DIEGO, CA, Jun 14, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will […]

ACN Newswire
Read More

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

indie 6 June
4 minutes

SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the […]

ACN Newswire

CUHK Professor Elaine Chow Receives “2022 Women’s Interprofessional Network of the American Diabetes Association Abstract Award” for Outstanding Research and Care in Diabetes

indie 5 June
2 minutes

HONG KONG, Jun 5, 2022 – (ACN Newswire via SEAPRWire.com) – Professor Elaine YK Chow from the Faculty of Medicine at The Chinese University of Hong Kong has received the […]

ACN Newswire
Read More

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US

indie 2 June
4 minutes

SYDNEY, Jun 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert […]

SEAPRWire

S’pore sets sights on being regional centre for clinical trials, from diabetes to cancer

admin 23 May
0 min

ACN Newswire
Read More

Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine

indie 13 May
14 minutes

SHANGHAI, CHINA, May 13, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces […]

ACN Newswire
Read More

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

indie 12 May
4 minutes

SYDNEY, May 12, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased […]

ACN Newswire
Read More

Novotech Acquires US CRO NCGS, Expands Global Expertise

indie 5 May
3 minutes

Singapore & Charlotte, NC, May 5, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion […]

ACN Newswire
Read More

SinoMab Announces IND APPLICATION FOR SN1011 APPROVED BY NMPA

indie 20 April
4 minutes

HONG KONG, Apr 20, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based […]

ACN Newswire
Read More

Avance Clinical进入Informa Pharma Intelligence 2022年亚太地区最佳CRO最终候选名单

tallulah 19 April
1 minute

ADELAIDE, AUS, Apr 19, 2022 – (亚太商讯 via SEAPRWire.com) – Avance Clinical是澳大利亚本地最大的CRO,致力于协助世界各地的生物科技及制药公司完成早...

ACN Newswire
Read More

Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

indie 19 April
4 minutes

ADELAIDE, AUS, Apr 19, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist […]

ACN Newswire
Read More

Avance Clinical Announces New Office Opening in Melbourne

indie 31 March
3 minutes

MELBOURNE, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to […]

ACN Newswire
Read More

Kindstar Globalgene Announces FY2021 Annual Results, Revenue Increases to RMB930.67 Million

indie 25 March
8 minutes

HONG KONG, Mar 25, 2022 – (ACN Newswire via SEAPRWire.com) – Kindstar Globalgene Technology, Inc. (“Kindstar Globalgene” or the “Company”, together with its subsidiaries, collectively the “Group”; stock code: 9960.HK), […]

ACN Newswire
Read More

Essex Bio-Technology Announces 2021 Financial Results

indie 22 March
10 minutes

HONG KONG, Mar 22, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the annual results for the year ended […]

JCN Newswire
Read More

Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the AD/PD 2022 Annual Meeting

ruth 11 March
3 minutes

TOKYO, Mar 11, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today the company will present research from its robust Alzheimer’s disease (AD) pipeline, including the latest […]

Previous1 2 3 4 Next

Menu

  • About Us
  • Contact Us
  • Term of Use

Category

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • Latest News
  • SEAPRWire

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS
Copyright © 2020 Singdaotimes.Com All rights reserved.